Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit H Mulsant

Showing results (411-420 of 607) with videos related to

Pageof 61
Sort By:
The American Journal of Psychiatry|March 1, 2002
Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patientsBruce G Pollock, Benoit H Mulsant, Jules Rosen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 25, 2005
Body pain and treatment response in late-life depressionJordan F Karp, Debra Weiner, Karen Seligman, et al.
Journal of Neuroengineering and Rehabilitation|May 16, 2023
Manipulating facial musculature with functional electrical stimulation as an intervention for major depressive disorder: a focused search of literature for a proposalIlya Demchenko, Naaz Desai, Stephanie N Iwasa, et al.
Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.
International Psychogeriatrics|January 3, 2023
Association between lean muscle mass and treatment-resistant late-life depression in the IRL-GRey randomized controlled trialNicholas J Ainsworth, Ram Brender, Neta Gotlieb, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 30, 2025
Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Résultats cognitifs après la stimulation magnétique transcrânienne pour le traitement de la dépression chez les personnes âgéesKatharina Göke, Shawn M McClintock, Linda Mah, et al.
Neuroimage. Clinical|January 28, 2019
Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depressionChemin Lin, Helmet T Karim, Marta Pecina, et al.
International Journal of Geriatric Psychiatry|June 11, 2016
Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot studyStephen F Smagula, Francis E Lotrich, Howard J Aizenstein, et al.
Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 25, 2024
Cognitive Profiles in Treatment-Resistant Late-Life Depression and Their Impact on Treatment OutcomesKatharina Göke, Shawn M McClintock, Linda Mah, et al.
Pageof 61

Showing results (411-420 of 607) with videos related to

Sort By:
Pageof 61
The American Journal of Psychiatry|March 1, 2002
Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patientsBruce G Pollock, Benoit H Mulsant, Jules Rosen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 25, 2005
Body pain and treatment response in late-life depressionJordan F Karp, Debra Weiner, Karen Seligman, et al.
Journal of Neuroengineering and Rehabilitation|May 16, 2023
Manipulating facial musculature with functional electrical stimulation as an intervention for major depressive disorder: a focused search of literature for a proposalIlya Demchenko, Naaz Desai, Stephanie N Iwasa, et al.
Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.
International Psychogeriatrics|January 3, 2023
Association between lean muscle mass and treatment-resistant late-life depression in the IRL-GRey randomized controlled trialNicholas J Ainsworth, Ram Brender, Neta Gotlieb, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 30, 2025
Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Résultats cognitifs après la stimulation magnétique transcrânienne pour le traitement de la dépression chez les personnes âgéesKatharina Göke, Shawn M McClintock, Linda Mah, et al.
Neuroimage. Clinical|January 28, 2019
Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depressionChemin Lin, Helmet T Karim, Marta Pecina, et al.
International Journal of Geriatric Psychiatry|June 11, 2016
Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot studyStephen F Smagula, Francis E Lotrich, Howard J Aizenstein, et al.
Journal of Affective Disorders|January 2, 2023
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II StudyJianmeng Song, Benoit H Mulsant, Marcos Sanches, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 25, 2024
Cognitive Profiles in Treatment-Resistant Late-Life Depression and Their Impact on Treatment OutcomesKatharina Göke, Shawn M McClintock, Linda Mah, et al.
Pageof 61